213 related articles for article (PubMed ID: 19094228)
21. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.
Jiang Y; Han J; Liu J; Zhang G; Wang L; Liu F; Zhang X; Zhao Y; Pang D
Breast Cancer Res Treat; 2011 Jul; 128(1):251-7. PubMed ID: 21197568
[TBL] [Abstract][Full Text] [Related]
22. The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients.
Gudmundsdottir ET; Barkardottir RB; Arason A; Gunnarsson H; Amundadottir LT; Agnarsson BA; Johannsson OT; Reynisdottir I
BMC Cancer; 2012 Dec; 12():621. PubMed ID: 23270421
[TBL] [Abstract][Full Text] [Related]
23. The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.
Bayraktar S; Thompson PA; Yoo SY; Do KA; Sahin AA; Arun BK; Bondy ML; Brewster AM
Oncologist; 2013; 18(5):493-500. PubMed ID: 23635555
[TBL] [Abstract][Full Text] [Related]
24. Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort.
Woolcott CG; Maskarinec G; Haiman CA; Verheus M; Pagano IS; Le Marchand L; Henderson BE; Kolonel LN
Breast Cancer Res; 2009; 11(1):R10. PubMed ID: 19232126
[TBL] [Abstract][Full Text] [Related]
25. Diverse associations between ESR1 polymorphism and breast cancer development and progression.
Ding SL; Yu JC; Chen ST; Hsu GC; Hsu HM; Ho JY; Lin YH; Chang CC; Fann CS; Cheng CW; Wu PE; Shen CY
Clin Cancer Res; 2010 Jul; 16(13):3473-84. PubMed ID: 20570923
[TBL] [Abstract][Full Text] [Related]
26. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
Li Y; Li Y; Wedrén S; Li G; Charn TH; Desai KV; Bonnard C; Czene K; Humphreys K; Darabi H; Einarsdóttir K; Heikkinen T; Aittomäki K; Blomqvist C; Chia KS; Nevanlinna H; Hall P; Liu ET; Liu J
Breast Cancer Res; 2011 Jan; 13(1):R10. PubMed ID: 21269472
[TBL] [Abstract][Full Text] [Related]
27. Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population.
He Y; Liu H; Chen Q; Sun X; Liu C; Shao Y
Tumour Biol; 2016 Jul; 37(7):9739-44. PubMed ID: 26803517
[TBL] [Abstract][Full Text] [Related]
28. IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.
Markkula A; Simonsson M; Ingvar C; Rose C; Jernström H
BMC Cancer; 2014 Oct; 14():759. PubMed ID: 25305747
[TBL] [Abstract][Full Text] [Related]
29. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
Antoniou AC; Beesley J; McGuffog L; Sinilnikova OM; Healey S; Neuhausen SL; Ding YC; Rebbeck TR; Weitzel JN; Lynch HT; Isaacs C; Ganz PA; Tomlinson G; Olopade OI; Couch FJ; Wang X; Lindor NM; Pankratz VS; Radice P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Viel A; Allavena A; Dall'Olio V; Peterlongo P; Szabo CI; Zikan M; Claes K; Poppe B; Foretova L; Mai PL; Greene MH; Rennert G; Lejbkowicz F; Glendon G; Ozcelik H; Andrulis IL; ; Thomassen M; Gerdes AM; Sunde L; Cruger D; Birk Jensen U; Caligo M; Friedman E; Kaufman B; Laitman Y; Milgrom R; Dubrovsky M; Cohen S; Borg A; Jernström H; Lindblom A; Rantala J; Stenmark-Askmalm M; Melin B; ; Nathanson K; Domchek S; Jakubowska A; Lubinski J; Huzarski T; Osorio A; Lasa A; Durán M; Tejada MI; Godino J; Benitez J; Hamann U; Kriege M; Hoogerbrugge N; van der Luijt RB; van Asperen CJ; Devilee P; Meijers-Heijboer EJ; Blok MJ; Aalfs CM; Hogervorst F; Rookus M; ; Cook M; Oliver C; Frost D; Conroy D; Evans DG; Lalloo F; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Hodgson S; Morrison PJ; Porteous ME; Walker L; Kennedy MJ; Dorkins H; Peock S; ; Godwin AK; Stoppa-Lyonnet D; de Pauw A; Mazoyer S; Bonadona V; Lasset C; Dreyfus H; Leroux D; Hardouin A; Berthet P; Faivre L; ; Loustalot C; Noguchi T; Sobol H; Rouleau E; Nogues C; Frénay M; Vénat-Bouvet L; ; Hopper JL; Daly MB; Terry MB; John EM; Buys SS; Yassin Y; Miron A; Goldgar D; ; Singer CF; Dressler AC; Gschwantler-Kaulich D; Pfeiler G; Hansen TV; Jønson L; Agnarsson BA; Kirchhoff T; Offit K; Devlin V; Dutra-Clarke A; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov E; Tihomirova L; Blanco I; Lazaro C; Ramus SJ; Sucheston L; Karlan BY; Gross J; Schmutzler R; Wappenschmidt B; Engel C; Meindl A; Lochmann M; Arnold N; Heidemann S; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Gadzicki D; Preisler-Adams S; Kast K; Schönbuchner I; Caldes T; de la Hoya M; Aittomäki K; Nevanlinna H; Simard J; Spurdle AB; Holland H; Chen X; ; Platte R; Chenevix-Trench G; Easton DF;
Cancer Res; 2010 Dec; 70(23):9742-54. PubMed ID: 21118973
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer subtypes and previously established genetic risk factors: a bayesian approach.
O'Brien KM; Cole SR; Engel LS; Bensen JT; Poole C; Herring AH; Millikan RC
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):84-97. PubMed ID: 24177593
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer.
Anghel A; Raica M; Narita D; Seclaman E; Nicola T; Ursoniu S; Anghel M; Popovici E
Neoplasma; 2010; 57(4):306-15. PubMed ID: 20429621
[TBL] [Abstract][Full Text] [Related]
32. The association of single nucleotide polymorphisms (SNPs) with breast density and breast cancer survival: the Malmö Diet and Cancer Study.
Sartor H; Brandt J; Grassmann F; Eriksson M; Czene K; Melander O; Zackrisson S
Acta Radiol; 2020 Oct; 61(10):1326-1334. PubMed ID: 32036684
[TBL] [Abstract][Full Text] [Related]
33. Previous GWAS hits in relation to young-onset breast cancer.
Shi M; O'Brien KM; Sandler DP; Taylor JA; Zaykin DV; Weinberg CR
Breast Cancer Res Treat; 2017 Jan; 161(2):333-344. PubMed ID: 27848153
[TBL] [Abstract][Full Text] [Related]
34. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.
Teraoka SN; Bernstein JL; Reiner AS; Haile RW; Bernstein L; Lynch CF; Malone KE; Stovall M; Capanu M; Liang X; Smith SA; Mychaleckyj J; Hou X; Mellemkjaer L; Boice JD; Siniard A; Duggan D; Thomas DC; ; Concannon P
Breast Cancer Res; 2011; 13(6):R114. PubMed ID: 22087758
[TBL] [Abstract][Full Text] [Related]
35. Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.
Brekelmans CT; Tilanus-Linthorst MM; Seynaeve C; vd Ouweland A; Menke-Pluymers MB; Bartels CC; Kriege M; van Geel AN; Burger CW; Eggermont AM; Meijers-Heijboer H; Klijn JG
Eur J Cancer; 2007 Mar; 43(5):867-76. PubMed ID: 17307353
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.
Rinella ES; Shao Y; Yackowski L; Pramanik S; Oratz R; Schnabel F; Guha S; LeDuc C; Campbell CL; Klugman SD; Terry MB; Senie RT; Andrulis IL; Daly M; John EM; Roses D; Chung WK; Ostrer H
Hum Genet; 2013 May; 132(5):523-36. PubMed ID: 23354978
[TBL] [Abstract][Full Text] [Related]
37. Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients.
Hemminki K; Müller-Myhsok B; Lichtner P; Engel C; Chen B; Burwinkel B; Försti A; Sutter C; Wappenschmidt B; Hellebrand H; Illig T; Arnold N; Niederacher D; Dworniczak B; Deissler H; Kast K; Gadzicki D; Meitinger T; Wichmann HE; Kiechle M; Bartram CR; Schmutzler RK; Meindl A
Int J Cancer; 2010 Jun; 126(12):2858-62. PubMed ID: 19856316
[TBL] [Abstract][Full Text] [Related]
38. Hormone-related pathways and risk of breast cancer subtypes in African American women.
Haddad SA; Lunetta KL; Ruiz-Narváez EA; Bensen JT; Hong CC; Sucheston-Campbell LE; Yao S; Bandera EV; Rosenberg L; Haiman CA; Troester MA; Ambrosone CB; Palmer JR
Breast Cancer Res Treat; 2015 Nov; 154(1):145-54. PubMed ID: 26458823
[TBL] [Abstract][Full Text] [Related]
39. Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population.
Tajbakhsh A; Javan FA; Rivandi M; Moezzi A; Abedini S; Asghari M; Farjami Z; Soltanian H; Shandiz FH; Kooshyar MM; Pasdar A
Mol Biol Rep; 2019 Feb; 46(1):805-811. PubMed ID: 30515698
[TBL] [Abstract][Full Text] [Related]
40. Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography.
Keller BM; McCarthy AM; Chen J; Armstrong K; Conant EF; Domchek SM; Kontos D
BMC Cancer; 2015 Mar; 15():143. PubMed ID: 25881232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
